Malignant Testicular Neoplasm — Trials

Malignant Testicular Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

177 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 26
Ph III recruiting: 3
Growth YoY: —
Industry share: 2%
Top sponsor: University Health Network, Toronto
Termination share: 35.3%
Trials / 1,000 deaths: 80.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 51–63 of 63 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06806917	Twenty Years' Experience in Retroperitoneal Lymph Node Dissection for Testicular Cancer in a Tertiary Referral Center	recruiting	—	65	IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER	1	Feb 4, 2025	clinicaltrials
NCT06684327	Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors	recruiting	Phase 2	100	Fudan UniversityOTHER	1	Dec 20, 2024